195 related articles for article (PubMed ID: 29486060)
1. Prevention of liver cancer with new curative hepatitis C antivirals: Real-world challenges.
Soriano V; Tefferi A
Cancer; 2018 Apr; 124(8):1647-1649. PubMed ID: 29486060
[No Abstract] [Full Text] [Related]
2. Viral hepatitis at a crossroad.
Lok AS; Pawlotsky JM
Gastroenterology; 2012 May; 142(6):1261-3. PubMed ID: 22537431
[No Abstract] [Full Text] [Related]
3. The oncogenic hepatitis C virus and direct-acting antivirals: economic implications for hepatocellular carcinoma in Medicaid beneficiaries with cirrhosis.
Mantravadi S
Am J Manag Care; 2017 Apr; 23(5 Spec No.):SP180-SP184. PubMed ID: 28665676
[No Abstract] [Full Text] [Related]
4. [Editorial commentary: Hepatitis C].
Pár A
Orv Hetil; 2015 May; 156(21):835. PubMed ID: 26038989
[No Abstract] [Full Text] [Related]
5. [Hepatitis C: diagnosis, anti-viral therapy, after-care. Hungarian consensus guideline].
Hunyady B; Gerlei Z; Gervain J; Horváth G; Lengyel G; Pár A; Rókusz L; Szalay F; Telegdy L; Tornai I; Werling K; Makara M
Orv Hetil; 2015 Mar; 156(9):343-51. PubMed ID: 25702254
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C: From inflammatory pathogenesis to anti-inflammatory/hepatoprotective therapy.
Li H; Huang MH; Jiang JD; Peng ZG
World J Gastroenterol; 2018 Dec; 24(47):5297-5311. PubMed ID: 30598575
[TBL] [Abstract][Full Text] [Related]
7. [Diagnosis, treatment, and follow-up of hepatitis C-virus related liver disease. Hungarian national consensus guideline].
Hunyady B; Gervain J; Horváth G; Makara M; Pár A; Szalay F; Telegdy L; Tornai I
Orv Hetil; 2014 Mar; 155 Suppl():3-24. PubMed ID: 24631886
[TBL] [Abstract][Full Text] [Related]
8. [Fifteen years of investigations on hepatitis C virus in Poland].
Juszczyk J
Przegl Epidemiol; 2005; 59(2):373-84. PubMed ID: 16190544
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of hepatitis B and C -- current standards].
Zeuzem S
Dtsch Med Wochenschr; 2004 Sep; 129 Suppl 2():S57-9. PubMed ID: 15368169
[No Abstract] [Full Text] [Related]
10. Ongoing alcohol consumptions counteracts the benefits of sustained virological response in patients with well compensated hepatitis C cirrhosis: an observational study.
Hernaez R; El-Serag H
Ann Hepatol; 2017 Jan-Feb 2017; 16(1):16-20. PubMed ID: 28051790
[No Abstract] [Full Text] [Related]
11. Timing of hepatitis C antiviral therapy in patients with advanced liver disease: a decision analysis model.
Saab S; Hunt DR; Stone MA; McClune A; Tong MJ
Liver Transpl; 2010 Jun; 16(6):748-59. PubMed ID: 20517909
[TBL] [Abstract][Full Text] [Related]
12. Viral hepatitis C in 2014--the beginning of the end?
Prelipcean CC; Gogălniceanu P; Mihai C
Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):272-8. PubMed ID: 25076687
[No Abstract] [Full Text] [Related]
13. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus.
AASLD/IDSA HCV Guidance Panel
Hepatology; 2015 Sep; 62(3):932-54. PubMed ID: 26111063
[No Abstract] [Full Text] [Related]
14. Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents.
Kanwal F; Kramer J; Asch SM; Chayanupatkul M; Cao Y; El-Serag HB
Gastroenterology; 2017 Oct; 153(4):996-1005.e1. PubMed ID: 28642197
[TBL] [Abstract][Full Text] [Related]
15. [Hepatitis B and hepatitis C, a high stake for public health: how to reconcile health cost control and public health expenses?].
Allerg Immunol (Paris); 1997 Sep; 29(7):215-8. PubMed ID: 9432191
[No Abstract] [Full Text] [Related]
16. Hepatitis C virus infection in children in the era of direct-acting antiviral.
Pawlowska M; Sobolewska-Pilarczyk M; Domagalski K
World J Gastroenterol; 2018 Jun; 24(24):2555-2566. PubMed ID: 29962813
[TBL] [Abstract][Full Text] [Related]
17. Viral Hepatitis: Knowledge and Treatments for Hepatitis B and C Virus and Associated Transplantation and Neoplasia.
Sherman KE; Shah VH
Gastroenterology; 2018 Feb; 154(3):453-456. PubMed ID: 29154778
[No Abstract] [Full Text] [Related]
18. Infections and organ transplantation: new challenges for prevention and treatment of hepatitis C virus.
Burra P; De Martin E
Transplant Proc; 2011; 43(6):2455-6. PubMed ID: 21839292
[TBL] [Abstract][Full Text] [Related]
19. Antiviral treatment for cirrhosis due to hepatitis C: a review.
Somasundaram A; Venkataraman J
Singapore Med J; 2012 Apr; 53(4):231-5. PubMed ID: 22511042
[TBL] [Abstract][Full Text] [Related]
20. Global burden of hepatitis C: considerations for healthcare providers in the United States.
Averhoff FM; Glass N; Holtzman D
Clin Infect Dis; 2012 Jul; 55 Suppl 1():S10-5. PubMed ID: 22715208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
